This contract opportunity is for the supply of medical materials and consumables as specified in the terms of reference. The contracting authority will respond clearly and completely to all requests for clarification or additional information 11 days before the deadline for submitting offers, in acc
Contract awarded. Originally published 10 months ago.
The procurement of Dimethyl Fumarate, Peginterferon Beta-1A, and Ocrelizumab is aimed at ensuring treatment for patients diagnosed with multiple sclerosis. These medicines have been included in the National Health Programs under the multiple sclerosis treatment subprogram, in accordance with the req
This contract involves the supply of disinfectants for the years 2023 to 2025, in accordance with the specifications outlined in the tender documents. Suppliers can request clarifications until 18 days before the deadline for submitting offers, and responses to these requests will be provided 11 day
This contract opportunity involves the supply of medical equipment as detailed in the attached specifications document. The contracting authority will respond clearly and completely to all requests for clarification or additional information on the 11th day before the deadline for submitting offers,
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
